Patent · US Active

Methods of treating cell proliferative disorders

US8227455B2 · kind B2 · utility

10Cited by
4References
40Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2006
Grant dateJul 24, 2012
Priority date
Expiry dateDec 12, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides methods for the treatment of cell proliferative disorders by administration of a Syk kinase or Syk/Flt-3 kinase inhibitor. Cell proliferative disorders treatable by the methods include, hematopoietic neoplasms and virally associated tumors. The compounds are also directed to therapeutic or prophylactic inhibition of tumor metastasis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.